ERBB2 and breast carcinoma: Genetic alterations in Her2 gene are found in almost the 30% of breast cancer (BC) patients and are associated with a poor prognosis (7), causing an increased protein expression on the tumor cell surface which leads to an increased cell proliferation, cell survival (8) and tumoral resistance to anticancer therapies.